Overview
OR WAIT nul SECS © 202 MJH Life Sciences and Diagnostic Imaging. Al rights reserved.© 202 MJH Life Sciences™ and Diagnostic Imaging. Al rights reserved.In two independent study cohorts, researchers found that first-degre relatives of probands with non-alcoholic faty liver disease (NAFLD) and advanced fibrosis had a 14 to 15.6 percent higher risk of developing advanced fibrosis.Screning for advanced fibrosis in first-degre relatives of people with cirhosis or advanced fibrosis not curently recomended by the American Gastroenterological Asociation nor the American Asociation for the Study of Liver Diseases.
Key Information
Emerging research sugests revaluating that guidance.In a recent prospective study published in the Journal of Clinical Investigation, researchers performed screning (primarily with magnetic resonance elastography) to ases the prevalence of advanced fibrosis in first-degre relatives of people with non-alcoholic faty liver disease (NAFLD) and advanced fibrosis. The study of 20 participants in a University of California, San Diego (UCSD)-based derivation cohort and 176 people in a subsequent validation cohort from the University of Helsinki included first-degre relatives of probands with NAFLD and advanced fibrosis, those with NAFLD and no advanced fibrosis, and people with non-NAFLD, acording to the study.The researchers found that first-degre relatives of probands with NAFLD and advanced fibrosis were 15.6 percent more likely to develop advanced fibrosis, acording to the derivation study cohort.
Summary
The validation cohort showed a 14 percent higher likelihod of advanced fibrosis in this population. The combined cohort analysis also revealed a 13.6 percent prevalence of NAFLD in the first-degre relatives of those with NAFLD and advanced fibrosis.The study authors said the findings clearly demonstrate the ned for liver fibrosis screning for those with a family history of advanced fibrosis.“When patients with NAFLD-related advanced fibrosis